Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
DTaP and Tdap Vaccines market report explains the definition, types, applications, major countries, and major players of the DTaP and Tdap Vaccines market. The report mainly contains different types, applications, and regional historical data from 2017-2021 and forecast data from 2022-2028.
The report contains qualitative and quantitative analysis of the entire industry.
The influence of COVID-19 has been considered in the report. Coronavirus Impact is included in Chapter 2. In addition, Strategic Analytics to Boost Productivity and Profitability is included in Chapter 3.
By Player:
Sanofi Pasteur
Merck Sharp & Dohme Corp
Pfizer Inc
Johnson & Johnson
GlaxoSmithKline
Astellas Pharma US Inc
Novartis AG
Seqirus
Emergent BioSolutions Inc
AstraZeneca
Protein Sciences Corporation
Lanzhou Institute of Biological Products CO LTD
By Type:
DTaP
Td
Tdap
By End-User:
Adult
Pediatric
By Region:
North America
-
United States
-
Canada
-
Mexico
Europe
-
Germany
-
UK
-
Spain
-
France
-
Italy
-
Denmark
-
Finland
-
Norway
-
Sweden
-
Poland
-
Russia
-
Turkey
Asia-Pacific
-
China
-
Japan
-
India
-
South Korea
-
Pakistan
-
Bangladesh
-
Indonesia
-
Thailand
-
Singapore
-
Malaysia
-
Philippines
-
Vietnam
-
Others
South America
-
Brazil
-
Colombia
-
Chile
-
Argentina
-
Venezuela
-
Peru
-
Puerto Rico
-
Ecuador
-
Others
GCC
-
Bahrain
-
Kuwait
-
Oman
-
Qatar
-
Saudi Arabia
-
United Arab Emirates
Africa
-
Nigeria
-
South Africa
-
Egypt
-
Algeriat
-
Others
Oceania
-
Australia
-
New Zealand
TABLE OF CONTENT
1. Global DTaP and Tdap Vaccines Executive Summary
-
1.1 Introduction
-
1.2 Market Panorama, 2022
2 Coronavirus Impact
-
2.1 DTaP and Tdap Vaccines Outlook to 2028- Original Forecasts
-
2.2 DTaP and Tdap Vaccines Outlook to 2028- COVID-19 Affected Forecasts
-
2.3 Impact on Industry
3 Strategic Analytics to Boost Productivity and Profitability
-
3.1 Potential Market Drivers and Opportunities
-
3.2 New Challenges and Strategies
-
3.3 Short Term and Long Term DTaP and Tdap Vaccines Market Trends
4 Key Inferences
5 Market Overview
-
5.1 Current Market Scenario
-
5.2 Porter's Five Forces Analysis
-
5.2.1 Bargaining Power of Suppliers
-
5.2.2 Bargaining Power of Consumers
-
5.2.3 Threat of New Entrants
-
5.2.4 Threat of Substitute Product and Services
-
5.2.5 Competitive Rivalry within the Industry
6 Global DTaP and Tdap Vaccines Market- Recent Developments
-
6.1 DTaP and Tdap Vaccines Market News and Developments
-
6.2 DTaP and Tdap Vaccines Market Deals Landscape
7 DTaP and Tdap Vaccines Raw Materials and Cost Structure Analysis
-
7.1 DTaP and Tdap Vaccines Key Raw Materials
-
7.2 DTaP and Tdap Vaccines Price Trend of Key Raw Materials
-
7.3 DTaP and Tdap Vaccines Key Suppliers of Raw Materials
-
7.4 DTaP and Tdap Vaccines Market Concentration Rate of Raw Materials
-
7.5 DTaP and Tdap Vaccines Cost Structure Analysis
-
7.5.1 DTaP and Tdap Vaccines Raw Materials Analysis
-
7.5.2 DTaP and Tdap Vaccines Labor Cost Analysis
-
7.5.3 DTaP and Tdap Vaccines Manufacturing Expenses Analysis
8 Global DTaP and Tdap Vaccines Import and Export Analysis (Top 10 Countries)
-
8.1 Global DTaP and Tdap Vaccines Import by Region (Top 10 Countries) (2017-2028)
-
8.2 Global DTaP and Tdap Vaccines Export by Region (Top 10 Countries) (2017-2028)
9 Global DTaP and Tdap Vaccines Market Outlook by Types and Applications to 2022
-
9.1 Global DTaP and Tdap Vaccines Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global DTaP Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Td Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Tdap Consumption and Growth Rate (2017-2022)
-
9.2 Global DTaP and Tdap Vaccines Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Adult Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Pediatric Consumption and Growth Rate (2017-2022)
10 Region and Country-wise DTaP and Tdap Vaccines Market Analysis and Outlook till 2022
-
10.1 Global DTaP and Tdap Vaccines Consumption (2017-2022)
-
10.2 North America Consumption Analysis
-
10.2.1 United States DTaP and Tdap Vaccines Consumption (2017-2022)
-
10.2.2 Canada DTaP and Tdap Vaccines Consumption (2017-2022)
-
10.2.3 Mexico DTaP and Tdap Vaccines Consumption (2017-2022)
-
10.3 Europe Consumption Analysis
-
10.3.1 Germany DTaP and Tdap Vaccines Consumption (2017-2022)
-
10.3.2 UK DTaP and Tdap Vaccines Consumption (2017-2022)
-
10.3.3 Spain DTaP and Tdap Vaccines Consumption (2017-2022)
-
10.3.4 Belgium DTaP and Tdap Vaccines Consumption (2017-2022)
-
10.3.5 France DTaP and Tdap Vaccines Consumption (2017-2022)
-
10.3.6 Italy DTaP and Tdap Vaccines Consumption (2017-2022)
-
10.3.7 Denmark DTaP and Tdap Vaccines Consumption (2017-2022)
-
10.3.8 Finland DTaP and Tdap Vaccines Consumption (2017-2022)
-
10.3.9 Norway DTaP and Tdap Vaccines Consumption (2017-2022)
-
10.3.10 Sweden DTaP and Tdap Vaccines Consumption (2017-2022)
-
10.3.11 Poland DTaP and Tdap Vaccines Consumption (2017-2022)
-
10.3.12 Russia DTaP and Tdap Vaccines Consumption (2017-2022)
-
10.3.13 Turkey DTaP and Tdap Vaccines Consumption (2017-2022)
-
10.4 APAC Consumption Analysis
-
10.4.1 China DTaP and Tdap Vaccines Consumption (2017-2022)
-
10.4.2 Japan DTaP and Tdap Vaccines Consumption (2017-2022)
-
10.4.3 India DTaP and Tdap Vaccines Consumption (2017-2022)
-
10.4.4 South Korea DTaP and Tdap Vaccines Consumption (2017-2022)
-
10.4.5 Pakistan DTaP and Tdap Vaccines Consumption (2017-2022)
-
10.4.6 Bangladesh DTaP and Tdap Vaccines Consumption (2017-2022)
-
10.4.7 Indonesia DTaP and Tdap Vaccines Consumption (2017-2022)
-
10.4.8 Thailand DTaP and Tdap Vaccines Consumption (2017-2022)
-
10.4.9 Singapore DTaP and Tdap Vaccines Consumption (2017-2022)
-
10.4.10 Malaysia DTaP and Tdap Vaccines Consumption (2017-2022)
-
10.4.11 Philippines DTaP and Tdap Vaccines Consumption (2017-2022)
-
10.4.12 Vietnam DTaP and Tdap Vaccines Consumption (2017-2022)
-
10.5 South America Consumption Analysis
-
10.5.1 Brazil DTaP and Tdap Vaccines Consumption (2017-2022)
-
10.5.2 Colombia DTaP and Tdap Vaccines Consumption (2017-2022)
-
10.5.3 Chile DTaP and Tdap Vaccines Consumption (2017-2022)
-
10.5.4 Argentina DTaP and Tdap Vaccines Consumption (2017-2022)
-
10.5.5 Venezuela DTaP and Tdap Vaccines Consumption (2017-2022)
-
10.5.6 Peru DTaP and Tdap Vaccines Consumption (2017-2022)
-
10.5.7 Puerto Rico DTaP and Tdap Vaccines Consumption (2017-2022)
-
10.5.8 Ecuador DTaP and Tdap Vaccines Consumption (2017-2022)
-
10.6 GCC Consumption Analysis
-
10.6.1 Bahrain DTaP and Tdap Vaccines Consumption (2017-2022)
-
10.6.2 Kuwait DTaP and Tdap Vaccines Consumption (2017-2022)
-
10.6.3 Oman DTaP and Tdap Vaccines Consumption (2017-2022)
-
10.6.4 Qatar DTaP and Tdap Vaccines Consumption (2017-2022)
-
10.6.5 Saudi Arabia DTaP and Tdap Vaccines Consumption (2017-2022)
-
10.6.6 United Arab Emirates DTaP and Tdap Vaccines Consumption (2017-2022)
-
10.7 Africa Consumption Analysis
-
10.7.1 Nigeria DTaP and Tdap Vaccines Consumption (2017-2022)
-
10.7.2 South Africa DTaP and Tdap Vaccines Consumption (2017-2022)
-
10.7.3 Egypt DTaP and Tdap Vaccines Consumption (2017-2022)
-
10.7.4 Algeria DTaP and Tdap Vaccines Consumption (2017-2022)
-
10.8 Oceania Consumption Analysis
-
10.8.1 Australia DTaP and Tdap Vaccines Consumption (2017-2022)
-
10.8.2 New Zealand DTaP and Tdap Vaccines Consumption (2017-2022)
11 Global DTaP and Tdap Vaccines Competitive Analysis
-
11.1 Sanofi Pasteur
-
11.1.1 Sanofi Pasteur Company Details
-
11.1.2 Sanofi Pasteur DTaP and Tdap Vaccines Sales, Price, Value and Gross Profit (2017-2022)
-
11.1.3 Sanofi Pasteur DTaP and Tdap Vaccines Main Business and Markets Served
-
11.1.4 Sanofi Pasteur DTaP and Tdap Vaccines Product Portfolio
-
11.1.5 Recent Research and Development Strategies
-
11.2 Merck Sharp & Dohme Corp
-
11.2.1 Merck Sharp & Dohme Corp Company Details
-
11.2.2 Merck Sharp & Dohme Corp DTaP and Tdap Vaccines Sales, Price, Value and Gross Profit (2017-2022)
-
11.2.3 Merck Sharp & Dohme Corp DTaP and Tdap Vaccines Main Business and Markets Served
-
11.2.4 Merck Sharp & Dohme Corp DTaP and Tdap Vaccines Product Portfolio
-
11.2.5 Recent Research and Development Strategies
-
11.3 Pfizer Inc
-
11.3.1 Pfizer Inc Company Details
-
11.3.2 Pfizer Inc DTaP and Tdap Vaccines Sales, Price, Value and Gross Profit (2017-2022)
-
11.3.3 Pfizer Inc DTaP and Tdap Vaccines Main Business and Markets Served
-
11.3.4 Pfizer Inc DTaP and Tdap Vaccines Product Portfolio
-
11.3.5 Recent Research and Development Strategies
-
11.4 Johnson & Johnson
-
11.4.1 Johnson & Johnson Company Details
-
11.4.2 Johnson & Johnson DTaP and Tdap Vaccines Sales, Price, Value and Gross Profit (2017-2022)
-
11.4.3 Johnson & Johnson DTaP and Tdap Vaccines Main Business and Markets Served
-
11.4.4 Johnson & Johnson DTaP and Tdap Vaccines Product Portfolio
-
11.4.5 Recent Research and Development Strategies
-
11.5 GlaxoSmithKline
-
11.5.1 GlaxoSmithKline Company Details
-
11.5.2 GlaxoSmithKline DTaP and Tdap Vaccines Sales, Price, Value and Gross Profit (2017-2022)
-
11.5.3 GlaxoSmithKline DTaP and Tdap Vaccines Main Business and Markets Served
-
11.5.4 GlaxoSmithKline DTaP and Tdap Vaccines Product Portfolio
-
11.5.5 Recent Research and Development Strategies
-
11.6 Astellas Pharma US Inc
-
11.6.1 Astellas Pharma US Inc Company Details
-
11.6.2 Astellas Pharma US Inc DTaP and Tdap Vaccines Sales, Price, Value and Gross Profit (2017-2022)
-
11.6.3 Astellas Pharma US Inc DTaP and Tdap Vaccines Main Business and Markets Served
-
11.6.4 Astellas Pharma US Inc DTaP and Tdap Vaccines Product Portfolio
-
11.6.5 Recent Research and Development Strategies
-
11.7 Novartis AG
-
11.7.1 Novartis AG Company Details
-
11.7.2 Novartis AG DTaP and Tdap Vaccines Sales, Price, Value and Gross Profit (2017-2022)
-
11.7.3 Novartis AG DTaP and Tdap Vaccines Main Business and Markets Served
-
11.7.4 Novartis AG DTaP and Tdap Vaccines Product Portfolio
-
11.7.5 Recent Research and Development Strategies
-
11.8 Seqirus
-
11.8.1 Seqirus Company Details
-
11.8.2 Seqirus DTaP and Tdap Vaccines Sales, Price, Value and Gross Profit (2017-2022)
-
11.8.3 Seqirus DTaP and Tdap Vaccines Main Business and Markets Served
-
11.8.4 Seqirus DTaP and Tdap Vaccines Product Portfolio
-
11.8.5 Recent Research and Development Strategies
-
11.9 Emergent BioSolutions Inc
-
11.9.1 Emergent BioSolutions Inc Company Details
-
11.9.2 Emergent BioSolutions Inc DTaP and Tdap Vaccines Sales, Price, Value and Gross Profit (2017-2022)
-
11.9.3 Emergent BioSolutions Inc DTaP and Tdap Vaccines Main Business and Markets Served
-
11.9.4 Emergent BioSolutions Inc DTaP and Tdap Vaccines Product Portfolio
-
11.9.5 Recent Research and Development Strategies
-
11.10 AstraZeneca
-
11.10.1 AstraZeneca Company Details
-
11.10.2 AstraZeneca DTaP and Tdap Vaccines Sales, Price, Value and Gross Profit (2017-2022)
-
11.10.3 AstraZeneca DTaP and Tdap Vaccines Main Business and Markets Served
-
11.10.4 AstraZeneca DTaP and Tdap Vaccines Product Portfolio
-
11.10.5 Recent Research and Development Strategies
-
11.11 Protein Sciences Corporation
-
11.11.1 Protein Sciences Corporation Company Details
-
11.11.2 Protein Sciences Corporation DTaP and Tdap Vaccines Sales, Price, Value and Gross Profit (2017-2022)
-
11.11.3 Protein Sciences Corporation DTaP and Tdap Vaccines Main Business and Markets Served
-
11.11.4 Protein Sciences Corporation DTaP and Tdap Vaccines Product Portfolio
-
11.11.5 Recent Research and Development Strategies
-
11.12 Lanzhou Institute of Biological Products CO LTD
-
11.12.1 Lanzhou Institute of Biological Products CO LTD Company Details
-
11.12.2 Lanzhou Institute of Biological Products CO LTD DTaP and Tdap Vaccines Sales, Price, Value and Gross Profit (2017-2022)
-
11.12.3 Lanzhou Institute of Biological Products CO LTD DTaP and Tdap Vaccines Main Business and Markets Served
-
11.12.4 Lanzhou Institute of Biological Products CO LTD DTaP and Tdap Vaccines Product Portfolio
-
11.12.5 Recent Research and Development Strategies
12 Global DTaP and Tdap Vaccines Market Outlook by Types and Applications to 2028
-
12.1 Global DTaP and Tdap Vaccines Consumption Forecast and Growth Rate by Type (2022-2028)
-
12.1.1 Global DTaP Consumption Forecast and Growth Rate (2022-2028)
-
12.1.2 Global Td Consumption Forecast and Growth Rate (2022-2028)
-
12.1.3 Global Tdap Consumption Forecast and Growth Rate (2022-2028)
-
12.2 Global DTaP and Tdap Vaccines Consumption Forecast and Growth Rate by Application (2022-2028)
-
12.2.1 Global Adult Consumption Forecast and Growth Rate (2022-2028)
-
12.2.2 Global Pediatric Consumption Forecast and Growth Rate (2022-2028)
13 Country-wise DTaP and Tdap Vaccines Market Analysis and Outlook to 2028
-
13.1 Global DTaP and Tdap Vaccines Consumption Forecast (2022-2028)
-
13.2 North America Consumption Analysis
-
13.2.1 United States DTaP and Tdap Vaccines Consumption Forecast (2022-2028)
-
13.2.2 Canada DTaP and Tdap Vaccines Consumption Forecast (2022-2028)
-
13.2.3 Mexico DTaP and Tdap Vaccines Consumption Forecast (2022-2028)
-
13.3 Europe Consumption Analysis
-
13.3.1 Germany DTaP and Tdap Vaccines Consumption Forecast (2022-2028)
-
13.3.2 UK DTaP and Tdap Vaccines Consumption Forecast (2022-2028)
-
13.3.3 Spain DTaP and Tdap Vaccines Consumption Forecast (2022-2028)
-
13.3.4 Belgium DTaP and Tdap Vaccines Consumption Forecast (2022-2028)
-
13.3.5 France DTaP and Tdap Vaccines Consumption Forecast (2022-2028)
-
13.3.6 Italy DTaP and Tdap Vaccines Consumption Forecast (2022-2028)
-
13.3.7 Denmark DTaP and Tdap Vaccines Consumption Forecast (2022-2028)
-
13.3.8 Finland DTaP and Tdap Vaccines Consumption Forecast (2022-2028)
-
13.3.9 Norway DTaP and Tdap Vaccines Consumption Forecast (2022-2028)
-
13.3.10 Sweden DTaP and Tdap Vaccines Consumption Forecast (2022-2028)
-
13.3.11 Poland DTaP and Tdap Vaccines Consumption Forecast (2022-2028)
-
13.3.12 Russia DTaP and Tdap Vaccines Consumption Forecast (2022-2028)
-
13.3.13 Turkey DTaP and Tdap Vaccines Consumption Forecast (2022-2028)
-
13.4 APAC Consumption Analysis
-
13.4.1 China DTaP and Tdap Vaccines Consumption Forecast (2022-2028)
-
13.4.2 Japan DTaP and Tdap Vaccines Consumption Forecast (2022-2028)
-
13.4.3 India DTaP and Tdap Vaccines Consumption Forecast (2022-2028)
-
13.4.4 South Korea DTaP and Tdap Vaccines Consumption Forecast (2022-2028)
-
13.4.5 Pakistan DTaP and Tdap Vaccines Consumption Forecast (2022-2028)
-
13.4.6 Bangladesh DTaP and Tdap Vaccines Consumption Forecast (2022-2028)
-
13.4.7 Indonesia DTaP and Tdap Vaccines Consumption Forecast (2022-2028)
-
13.4.8 Thailand DTaP and Tdap Vaccines Consumption Forecast (2022-2028)
-
13.4.9 Singapore DTaP and Tdap Vaccines Consumption Forecast (2022-2028)
-
13.4.10 Malaysia DTaP and Tdap Vaccines Consumption Forecast (2022-2028)
-
13.4.11 Philippines DTaP and Tdap Vaccines Consumption Forecast (2022-2028)
-
13.4.12 Vietnam DTaP and Tdap Vaccines Consumption Forecast (2022-2028)
-
13.5 South America Consumption Analysis
-
13.5.1 Brazil DTaP and Tdap Vaccines Consumption Forecast (2022-2028)
-
13.5.2 Colombia DTaP and Tdap Vaccines Consumption Forecast (2022-2028)
-
13.5.3 Chile DTaP and Tdap Vaccines Consumption Forecast (2022-2028)
-
13.5.4 Argentina DTaP and Tdap Vaccines Consumption Forecast (2022-2028)
-
13.5.5 Venezuela DTaP and Tdap Vaccines Consumption Forecast (2022-2028)
-
13.5.6 Peru DTaP and Tdap Vaccines Consumption Forecast (2022-2028)
-
13.5.7 Puerto Rico DTaP and Tdap Vaccines Consumption Forecast (2022-2028)
-
13.5.8 Ecuador DTaP and Tdap Vaccines Consumption Forecast (2022-2028)
-
13.6 GCC Consumption Analysis
-
13.6.1 Bahrain DTaP and Tdap Vaccines Consumption Forecast (2022-2028)
-
13.6.2 Kuwait DTaP and Tdap Vaccines Consumption Forecast (2022-2028)
-
13.6.3 Oman DTaP and Tdap Vaccines Consumption Forecast (2022-2028)
-
13.6.4 Qatar DTaP and Tdap Vaccines Consumption Forecast (2022-2028)
-
13.6.5 Saudi Arabia DTaP and Tdap Vaccines Consumption Forecast (2022-2028)
-
13.6.6 United Arab Emirates DTaP and Tdap Vaccines Consumption Forecast (2022-2028)
-
13.7 Africa Consumption Analysis
-
13.7.1 Nigeria DTaP and Tdap Vaccines Consumption Forecast (2022-2028)
-
13.7.2 South Africa DTaP and Tdap Vaccines Consumption Forecast (2022-2028)
-
13.7.3 Egypt DTaP and Tdap Vaccines Consumption Forecast (2022-2028)
-
13.7.4 Algeria DTaP and Tdap Vaccines Consumption Forecast (2022-2028)
-
13.8 Oceania Consumption Analysis
-
13.8.1 Australia DTaP and Tdap Vaccines Consumption Forecast (2022-2028)
-
13.8.2 New Zealand DTaP and Tdap Vaccines Consumption Forecast (2022-2028)
14 Conclusions
The List of Tables and Figures
-
Table Definition of DTaP and Tdap Vaccines
-
Figure of DTaP and Tdap Vaccines Picture
-
Table Global DTaP and Tdap Vaccines Import by Region (Top 10 Countries) (2017-2028)
-
Table Global DTaP and Tdap Vaccines Export by Region (Top 10 Countries) (2017-2028)
-
Figure Global DTaP Consumption and Growth Rate (2017-2022)
-
Figure Global Td Consumption and Growth Rate (2017-2022)
-
Figure Global Tdap Consumption and Growth Rate (2017-2022)
-
Figure Global Adult Consumption and Growth Rate (2017-2022)
-
Figure Global Pediatric Consumption and Growth Rate (2017-2022)
-
Figure Global DTaP and Tdap Vaccines Consumption by Country (2017-2022)
-
Table North America DTaP and Tdap Vaccines Consumption by Country (2017-2022)
-
Figure United States DTaP and Tdap Vaccines Consumption and Growth Rate (2017-2022)
-
Figure Canada DTaP and Tdap Vaccines Consumption and Growth Rate (2017-2022)
-
Figure Mexico DTaP and Tdap Vaccines Consumption and Growth Rate (2017-2022)
-
Table Europe DTaP and Tdap Vaccines Consumption by Country (2017-2022)
-
Figure Germany DTaP and Tdap Vaccines Consumption and Growth Rate (2017-2022)
-
Figure UK DTaP and Tdap Vaccines Consumption and Growth Rate (2017-2022)
-
Figure Spain DTaP and Tdap Vaccines Consumption and Growth Rate (2017-2022)
-
Figure Belgium DTaP and Tdap Vaccines Consumption and Growth Rate (2017-2022)
-
Figure France DTaP and Tdap Vaccines Consumption and Growth Rate (2017-2022)
-
Figure Italy DTaP and Tdap Vaccines Consumption and Growth Rate (2017-2022)
-
Figure Denmark DTaP and Tdap Vaccines Consumption and Growth Rate (2017-2022)
-
Figure Finland DTaP and Tdap Vaccines Consumption and Growth Rate (2017-2022)
-
Figure Norway DTaP and Tdap Vaccines Consumption and Growth Rate (2017-2022)
-
Figure Sweden DTaP and Tdap Vaccines Consumption and Growth Rate (2017-2022)
-
Figure Poland DTaP and Tdap Vaccines Consumption and Growth Rate (2017-2022)
-
Figure Russia DTaP and Tdap Vaccines Consumption and Growth Rate (2017-2022)
-
Figure Turkey DTaP and Tdap Vaccines Consumption and Growth Rate (2017-2022)
-
Table APAC DTaP and Tdap Vaccines Consumption by Country (2017-2022)
-
Figure China DTaP and Tdap Vaccines Consumption and Growth Rate (2017-2022)
-
Figure Japan DTaP and Tdap Vaccines Consumption and Growth Rate (2017-2022)
-
Figure India DTaP and Tdap Vaccines Consumption and Growth Rate (2017-2022)
-
Figure South Korea DTaP and Tdap Vaccines Consumption and Growth Rate (2017-2022)
-
Figure Pakistan DTaP and Tdap Vaccines Consumption and Growth Rate (2017-2022)
-
Figure Bangladesh DTaP and Tdap Vaccines Consumption and Growth Rate (2017-2022)
-
Figure Indonesia DTaP and Tdap Vaccines Consumption and Growth Rate (2017-2022)
-
Figure Thailand DTaP and Tdap Vaccines Consumption and Growth Rate (2017-2022)
-
Figure Singapore DTaP and Tdap Vaccines Consumption and Growth Rate (2017-2022)
-
Figure Malaysia DTaP and Tdap Vaccines Consumption and Growth Rate (2017-2022)
-
Figure Philippines DTaP and Tdap Vaccines Consumption and Growth Rate (2017-2022)
-
Figure Vietnam DTaP and Tdap Vaccines Consumption and Growth Rate (2017-2022)
-
Table South America DTaP and Tdap Vaccines Consumption by Country (2017-2022)
-
Figure Brazil DTaP and Tdap Vaccines Consumption and Growth Rate (2017-2022)
-
Figure Colombia DTaP and Tdap Vaccines Consumption and Growth Rate (2017-2022)
-
Figure Chile DTaP and Tdap Vaccines Consumption and Growth Rate (2017-2022)
-
Figure Argentina DTaP and Tdap Vaccines Consumption and Growth Rate (2017-2022)
-
Figure Venezuela DTaP and Tdap Vaccines Consumption and Growth Rate (2017-2022)
-
Figure Peru DTaP and Tdap Vaccines Consumption and Growth Rate (2017-2022)
-
Figure Puerto Rico DTaP and Tdap Vaccines Consumption and Growth Rate (2017-2022)
-
Figure Ecuador DTaP and Tdap Vaccines Consumption and Growth Rate (2017-2022)
-
Table GCC DTaP and Tdap Vaccines Consumption by Country (2017-2022)
-
Figure Bahrain DTaP and Tdap Vaccines Consumption and Growth Rate (2017-2022)
-
Figure Kuwait DTaP and Tdap Vaccines Consumption and Growth Rate (2017-2022)
-
Figure Oman DTaP and Tdap Vaccines Consumption and Growth Rate (2017-2022)
-
Figure Qatar DTaP and Tdap Vaccines Consumption and Growth Rate (2017-2022)
-
Figure Saudi Arabia DTaP and Tdap Vaccines Consumption and Growth Rate (2017-2022)
-
Figure United Arab Emirates DTaP and Tdap Vaccines Consumption and Growth Rate (2017-2022)
-
Table Africa DTaP and Tdap Vaccines Consumption by Country (2017-2022)
-
Figure Nigeria DTaP and Tdap Vaccines Consumption and Growth Rate (2017-2022)
-
Figure South Africa DTaP and Tdap Vaccines Consumption and Growth Rate (2017-2022)
-
Figure Egypt DTaP and Tdap Vaccines Consumption and Growth Rate (2017-2022)
-
Figure Algeria DTaP and Tdap Vaccines Consumption and Growth Rate (2017-2022)
-
Table Oceania DTaP and Tdap Vaccines Consumption by Country (2017-2022)
-
Figure Australia DTaP and Tdap Vaccines Consumption and Growth Rate (2017-2022)
-
Figure New Zealand DTaP and Tdap Vaccines Consumption and Growth Rate (2017-2022)
-
Table Sanofi Pasteur Company Details
-
Table Sanofi Pasteur DTaP and Tdap Vaccines Sales, Price, Value and Gross Profit (2017-2022)
-
Table Sanofi Pasteur DTaP and Tdap Vaccines Main Business and Markets Served
-
Table Sanofi Pasteur DTaP and Tdap Vaccines Product Portfolio
-
Table Merck Sharp & Dohme Corp Company Details
-
Table Merck Sharp & Dohme Corp DTaP and Tdap Vaccines Sales, Price, Value and Gross Profit (2017-2022)
-
Table Merck Sharp & Dohme Corp DTaP and Tdap Vaccines Main Business and Markets Served
-
Table Merck Sharp & Dohme Corp DTaP and Tdap Vaccines Product Portfolio
-
Table Pfizer Inc Company Details
-
Table Pfizer Inc DTaP and Tdap Vaccines Sales, Price, Value and Gross Profit (2017-2022)
-
Table Pfizer Inc DTaP and Tdap Vaccines Main Business and Markets Served
-
Table Pfizer Inc DTaP and Tdap Vaccines Product Portfolio
-
Table Johnson & Johnson Company Details
-
Table Johnson & Johnson DTaP and Tdap Vaccines Sales, Price, Value and Gross Profit (2017-2022)
-
Table Johnson & Johnson DTaP and Tdap Vaccines Main Business and Markets Served
-
Table Johnson & Johnson DTaP and Tdap Vaccines Product Portfolio
-
Table GlaxoSmithKline Company Details
-
Table GlaxoSmithKline DTaP and Tdap Vaccines Sales, Price, Value and Gross Profit (2017-2022)
-
Table GlaxoSmithKline DTaP and Tdap Vaccines Main Business and Markets Served
-
Table GlaxoSmithKline DTaP and Tdap Vaccines Product Portfolio
-
Table Astellas Pharma US Inc Company Details
-
Table Astellas Pharma US Inc DTaP and Tdap Vaccines Sales, Price, Value and Gross Profit (2017-2022)
-
Table Astellas Pharma US Inc DTaP and Tdap Vaccines Main Business and Markets Served
-
Table Astellas Pharma US Inc DTaP and Tdap Vaccines Product Portfolio
-
Table Novartis AG Company Details
-
Table Novartis AG DTaP and Tdap Vaccines Sales, Price, Value and Gross Profit (2017-2022)
-
Table Novartis AG DTaP and Tdap Vaccines Main Business and Markets Served
-
Table Novartis AG DTaP and Tdap Vaccines Product Portfolio
-
Table Seqirus Company Details
-
Table Seqirus DTaP and Tdap Vaccines Sales, Price, Value and Gross Profit (2017-2022)
-
Table Seqirus DTaP and Tdap Vaccines Main Business and Markets Served
-
Table Seqirus DTaP and Tdap Vaccines Product Portfolio
-
Table Emergent BioSolutions Inc Company Details
-
Table Emergent BioSolutions Inc DTaP and Tdap Vaccines Sales, Price, Value and Gross Profit (2017-2022)
-
Table Emergent BioSolutions Inc DTaP and Tdap Vaccines Main Business and Markets Served
-
Table Emergent BioSolutions Inc DTaP and Tdap Vaccines Product Portfolio
-
Table AstraZeneca Company Details
-
Table AstraZeneca DTaP and Tdap Vaccines Sales, Price, Value and Gross Profit (2017-2022)
-
Table AstraZeneca DTaP and Tdap Vaccines Main Business and Markets Served
-
Table AstraZeneca DTaP and Tdap Vaccines Product Portfolio
-
Table Protein Sciences Corporation Company Details
-
Table Protein Sciences Corporation DTaP and Tdap Vaccines Sales, Price, Value and Gross Profit (2017-2022)
-
Table Protein Sciences Corporation DTaP and Tdap Vaccines Main Business and Markets Served
-
Table Protein Sciences Corporation DTaP and Tdap Vaccines Product Portfolio
-
Table Lanzhou Institute of Biological Products CO LTD Company Details
-
Table Lanzhou Institute of Biological Products CO LTD DTaP and Tdap Vaccines Sales, Price, Value and Gross Profit (2017-2022)
-
Table Lanzhou Institute of Biological Products CO LTD DTaP and Tdap Vaccines Main Business and Markets Served
-
Table Lanzhou Institute of Biological Products CO LTD DTaP and Tdap Vaccines Product Portfolio
-
Figure Global DTaP Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Td Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Tdap Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Adult Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Pediatric Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global DTaP and Tdap Vaccines Consumption Forecast by Country (2022-2028)
-
Table North America DTaP and Tdap Vaccines Consumption Forecast by Country (2022-2028)
-
Figure United States DTaP and Tdap Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Figure Canada DTaP and Tdap Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Figure Mexico DTaP and Tdap Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe DTaP and Tdap Vaccines Consumption Forecast by Country (2022-2028)
-
Figure Germany DTaP and Tdap Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Figure UK DTaP and Tdap Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Figure Spain DTaP and Tdap Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Figure Belgium DTaP and Tdap Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Figure France DTaP and Tdap Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Figure Italy DTaP and Tdap Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Figure Denmark DTaP and Tdap Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Figure Finland DTaP and Tdap Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Figure Norway DTaP and Tdap Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Figure Sweden DTaP and Tdap Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Figure Poland DTaP and Tdap Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Figure Russia DTaP and Tdap Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Figure Turkey DTaP and Tdap Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Table APAC DTaP and Tdap Vaccines Consumption Forecast by Country (2022-2028)
-
Figure China DTaP and Tdap Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan DTaP and Tdap Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Figure India DTaP and Tdap Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea DTaP and Tdap Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Figure Pakistan DTaP and Tdap Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Figure Bangladesh DTaP and Tdap Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Figure Indonesia DTaP and Tdap Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Figure Thailand DTaP and Tdap Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Figure Singapore DTaP and Tdap Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Figure Malaysia DTaP and Tdap Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Figure Philippines DTaP and Tdap Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Figure Vietnam DTaP and Tdap Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Table South America DTaP and Tdap Vaccines Consumption Forecast by Country (2022-2028)
-
Figure Brazil DTaP and Tdap Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Figure Colombia DTaP and Tdap Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Figure Chile DTaP and Tdap Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Figure Argentina DTaP and Tdap Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Figure Venezuela DTaP and Tdap Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Figure Peru DTaP and Tdap Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Figure Puerto Rico DTaP and Tdap Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Figure Ecuador DTaP and Tdap Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Table GCC DTaP and Tdap Vaccines Consumption Forecast by Country (2022-2028)
-
Figure Bahrain DTaP and Tdap Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Figure Kuwait DTaP and Tdap Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Figure Oman DTaP and Tdap Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Figure Qatar DTaP and Tdap Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Figure Saudi Arabia DTaP and Tdap Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Figure United Arab Emirates DTaP and Tdap Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Table Africa DTaP and Tdap Vaccines Consumption Forecast by Country (2022-2028)
-
Figure Nigeria DTaP and Tdap Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Africa DTaP and Tdap Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Figure Egypt DTaP and Tdap Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Figure Algeria DTaP and Tdap Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Table Oceania DTaP and Tdap Vaccines Consumption Forecast by Country (2022-2028)
-
Figure Australia DTaP and Tdap Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Figure New Zealand DTaP and Tdap Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
